Rockefeller Capital Management »

Halozyme Therapeutics shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 71k 36.96
2023-09-30 $2.7M 70k 38.20
2023-06-30 $2.0M 57k 36.07
2023-03-31 $1.4M 37k 38.18
2022-12-31 $1.9M 33k 56.90
2022-09-30 $395k 10k 39.44
2022-06-30 $0 11k 0.00
2022-03-31 $331k 8.3k 39.85
2021-12-31 $343k 8.5k 40.12
2021-09-30 $338k 8.3k 40.66
2021-06-30 $26k 573 45.38
2021-03-31 $22k 533 41.28
2020-12-31 $21k 500 42.00
2020-09-30 $13k 500 26.00
2020-06-30 $163k 6.1k 26.84
2020-03-31 $131k 7.3k 17.93
2019-12-31 $9.0k 500 18.00